trial · primary record
Bedaquiline
Rifampicin-Resistant Pulmonary Tuberculosis
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 532 |
| Primary completion | 2028-09-29 |
| Primary endpoint | Proportion of participants with an unfavorable outcome by 12 months post-randomization. |
| Registry ID | NCT07209761 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:06.207Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07209761
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.